• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/4

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

4 Cards in this Set

  • Front
  • Back
Degeneration of the RPE which may affect vision of patients using quinolones.
• Both medications are antimalarials, which are also commonly used to treat rheumatoid arthritis & lupus erythematosus
Chloroquine/Hydroxychloroquine
Retinopathy
What's the management of Hydroxychloroquine Retinopathy?
Management:
1. Appropriate monitoring of patients at risk.
2. Prompt discontinuation of medication:
- communicate with treating physician (often able to change meds)
- patients with mild RPE changes may improve, advanced cases may continue to worsen.

OD Monitoring (of pt’s taking hydroxychloroquine)

All patients should have a baseline eye exam when quinolone meds first prescribed:
1. Central VF Testing
2. Color Vision Testing
What are some signs/symptoms of Hydroxychloroquine Retinopathy?
• Initial symptom is subtle paracentral scotoma and/or color vision defects
– VA initially normal
– may proceed observable fundus changes

• Initial sign is loss of foveal reflex and subtle parafoveal RPE stippling

• Later a ring of parafoveal RPE atrophy develops
– “bulls-eye” maculopathy
– VA reduced as this
becomes more apparent

• Eventually marked atrophy of RPE throughout posterior pole with “choroidal show” and pigment clumping
– VA markedly reduced and arterioles attenuated
What are some diagnostic methods for Hydroxychloroquine Retinopathy?
Diagnostic Method
Based on characteristic symptoms/signs in patients taking these meds